4BMM
Crystal structure of Trypanosoma cruzi CYP51 bound to the inhibitor (R)-N-(3-(1H-indol-3-yl)-1-oxo-1-(pyridin-4-ylamino)propan-2-yl)-2',3, 5'-trifluoro-(1,1'-biphenyl)-4-carboxamide
Summary for 4BMM
Entry DOI | 10.2210/pdb4bmm/pdb |
Related | 4C0C 4UQH |
Descriptor | STEROL 14-ALPHA DEMETHYLASE, PROTOPORPHYRIN IX CONTAINING FE, 4-[2,5-bis(fluoranyl)phenyl]-2-fluoranyl-N-[(2R)-3-(1H-indol-3-yl)-1-oxidanylidene-1-(pyridin-4-ylamino)propan-2-yl]benzamide, ... (4 entities in total) |
Functional Keywords | oxidoreductase, sterol biosynthesis, chagas disease |
Biological source | TRYPANOSOMA CRUZI |
Cellular location | Membrane; Single-pass membrane protein (Potential): Q7Z1V1 |
Total number of polymer chains | 4 |
Total formula weight | 217671.22 |
Authors | Choi, J.Y.,Calvet, C.M.,Gunatilleke, S.S.,Roush, W.R.,McKerrow, J.H.,Podust, L.M. (deposition date: 2013-05-09, release date: 2014-06-11, Last modification date: 2023-12-20) |
Primary citation | Calvet, C.M.,Vieira, D.F.,Choi, J.Y.,Kellar, D.,Cameron, M.D.,Siqueira-Neto, J.L.,Gut, J.,Johnston, J.B.,Lin, L.,Khan, S.,Mckerrow, J.H.,Roush, W.R.,Podust, L.M. 4-Aminopyridyl-Based Cyp51 Inhibitors as Anti-Trypanosoma Cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency. J.Med.Chem., 57:6989-, 2014 Cited by PubMed: 25101801DOI: 10.1021/JM500448U PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.84 Å) |
Structure validation
Download full validation report